Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
A Case Study on How Brand Equity and Service Quality Shape Revisit Intention in Luxury Hospitality The hospitality industry is rapidly evolving through digital transformation, giving rise to hybrid ...